TRCT
IMUC

Tower Research Capital (TRC)’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Tower Research Capital (TRC)’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-45
Closed -$1K – 5801
2015
Q4 		$1K Buy
+45
New +$744 ﹤0.01% 4365
2014
Q4 		– Sell
-42
Closed -$1K – 5569
2014
Q3 		$1K Sell
42
-8
-16% -$308 ﹤0.01% 4332
2014
Q2 		$2K Buy
+50
New +$2.41K ﹤0.01% 3590
2014
Q1 		– Sell
-159
Closed -$6K – 5647
2013
Q4 		$6K Buy
159
+138
+657% +$13.1K ﹤0.01% 3482
2013
Q3 		$2K Sell
21
-309
-94% -$33.9K ﹤0.01% 4244
2013
Q2 		$26K Buy
+330
New +$31.6K ﹤0.01% 1489

Other funds holding IMUC

SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.6B AUM 27.3% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $2.24B AUM 17.11% 1-Year Est. Return